HSBC Holdings
CSTL icon

HSBC Holdings’s Castle Biosciences CSTL Stock Holding History

HSBC Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,486
Closed -$760K – 2963
2025
Q4 		$760K Sell
19,486
-13,747
-41% -$443K ﹤0.01% 2087
2025
Q3 		$749K Sell
33,233
-785
-2% -$15.9K ﹤0.01% 1914
2025
Q2 		$691K Buy
34,018
+14,391
+73% +$266K ﹤0.01% 1987
2025
Q1 		$391K Sell
19,627
-46
-0.2% -$1.14K ﹤0.01% 2211
2024
Q4 		$519K Sell
19,673
-3,434
-15% -$105K ﹤0.01% 2158
2024
Q3 		$654K Sell
23,107
-10,745
-32% -$273K ﹤0.01% 1879
2024
Q2 		$714K Sell
33,852
-616
-2% -$13.7K ﹤0.01% 1819
2024
Q1 		$763K Buy
+34,468
New +$750K ﹤0.01% 1897

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's CSTL Position: Q1 2026 in Review

HSBC Holdings sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 19,486 shares — an estimated $760K sold.

HSBC Holdings first reported a position in CSTL in Q1 2024 and held it in 8 quarters. The position peaked at $763K in Q1 2024. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • HSBC Holdings reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 19,486 Castle Biosciences shares in Q1 2026, an estimated $760K.
  • HSBC Holdings first reported a position in Castle Biosciences in Q1 2024 and held it in 8 quarters.
  • HSBC Holdings's Castle Biosciences position peaked at $763K in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.